These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 18568181

  • 1. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
    Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G.
    Rep Med Guidel Outcomes Res; 2003 Jan 24; 14(2):5-7. PubMed ID: 12776699
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators.
    N Engl J Med; 2008 Dec 04; 359(23):2417-28. PubMed ID: 19052124
    [Abstract] [Full Text] [Related]

  • 10. The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
    Bakris G, Hester A, Weber M, Dahlof B, Pitt B, Velasquez E, Staikos-Byrne L, Shi V, Jamerson K, ACCOMPLISH Investigators.
    J Cardiometab Syndr; 2008 Dec 04; 3(4):229-33. PubMed ID: 19040592
    [Abstract] [Full Text] [Related]

  • 11. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.
    Circulation; 2006 May 09; 113(18):2201-10. PubMed ID: 16651474
    [Abstract] [Full Text] [Related]

  • 12. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
    Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA.
    J Am Heart Assoc; 2018 Jan 04; 7(1):. PubMed ID: 29301757
    [Abstract] [Full Text] [Related]

  • 13. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR, Whelton PK, ALLHAT Collaborative Research Group.
    N Engl J Med; 2009 Mar 12; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract] [Full Text] [Related]

  • 14. [Amlodipine is the better partner].
    Einecke D.
    MMW Fortschr Med; 2008 Apr 17; 150(16):13-4. PubMed ID: 18557108
    [No Abstract] [Full Text] [Related]

  • 15. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K.
    J Cardiovasc Pharmacol; 2008 Jun 17; 51(6):590-5. PubMed ID: 18520951
    [Abstract] [Full Text] [Related]

  • 16. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
    Schillaci G, Verdecchia P.
    Ital Heart J Suppl; 2000 Sep 17; 1(9):1215-7. PubMed ID: 11140297
    [No Abstract] [Full Text] [Related]

  • 17. ACCOMPLISH the goal: hypertension and beyond.
    Siragy HM.
    Curr Hypertens Rep; 2009 Aug 17; 11(4):231-2. PubMed ID: 19602321
    [No Abstract] [Full Text] [Related]

  • 18. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr 17; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 19. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL, Toto RD, McCullough PA.
    J Hum Hypertens; 2005 Feb 17; 19(2):139-44. PubMed ID: 15457206
    [Abstract] [Full Text] [Related]

  • 20. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.